MMP1
Basic information
Region (hg38): 11:102789401-102798160
Previous symbols: [ "CLG" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the MMP1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 5 | |||||
missense | 29 | 37 | ||||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 3 | 2 | 5 | |||
non coding | 27 | 27 | ||||
Total | 0 | 0 | 30 | 10 | 31 |
Variants in MMP1
This is a list of pathogenic ClinVar variants found in the MMP1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
11-102790143-G-A | Benign (Jun 19, 2021) | |||
11-102790228-A-G | Benign (Nov 12, 2018) | |||
11-102790349-G-A | Benign (Jun 19, 2021) | |||
11-102790368-T-C | Benign (Jun 19, 2021) | |||
11-102790421-C-A | not specified | Uncertain significance (Dec 16, 2021) | ||
11-102790433-C-T | not specified | Uncertain significance (May 04, 2022) | ||
11-102790462-T-C | not specified | Uncertain significance (Aug 28, 2024) | ||
11-102790477-G-C | not specified | Uncertain significance (Jun 25, 2024) | ||
11-102790483-A-G | not specified | Uncertain significance (May 16, 2024) | ||
11-102790508-G-C | not specified | Uncertain significance (May 06, 2024) | ||
11-102790512-T-C | not specified | Uncertain significance (Jul 10, 2024) | ||
11-102790545-T-G | Benign (Nov 12, 2018) | |||
11-102790704-A-G | Benign (Dec 31, 2019) | |||
11-102790787-A-T | Likely benign (Dec 31, 2019) | |||
11-102790806-C-T | not specified | Likely benign (Sep 27, 2024) | ||
11-102790864-A-G | Benign (Jun 19, 2021) | |||
11-102790934-G-A | Benign (Nov 12, 2018) | |||
11-102791026-G-A | Benign (Nov 12, 2018) | |||
11-102791082-G-C | Benign (Nov 12, 2018) | |||
11-102791357-A-C | not specified | Uncertain significance (Aug 17, 2022) | ||
11-102791397-C-T | not specified | Uncertain significance (Dec 09, 2023) | ||
11-102791398-G-C | not specified | Uncertain significance (Nov 26, 2024) | ||
11-102791400-T-C | not specified | Uncertain significance (Jun 01, 2022) | ||
11-102791409-C-T | MMP1-related disorder | Benign (May 08, 2017) | ||
11-102791431-G-T | not specified | Likely benign (Nov 13, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
MMP1 | protein_coding | protein_coding | ENST00000315274 | 10 | 8241 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
7.72e-18 | 0.00214 | 122374 | 24 | 3347 | 125745 | 0.0135 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -1.12 | 308 | 258 | 1.20 | 0.0000134 | 3131 |
Missense in Polyphen | 112 | 95.573 | 1.1719 | 1190 | ||
Synonymous | -0.0725 | 92 | 91.1 | 1.01 | 0.00000487 | 860 |
Loss of Function | -0.413 | 25 | 22.9 | 1.09 | 0.00000107 | 268 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0131 | 0.0131 |
Ashkenazi Jewish | 0.00427 | 0.00428 |
East Asian | 0.00158 | 0.00158 |
Finnish | 0.0126 | 0.0125 |
European (Non-Finnish) | 0.0201 | 0.0201 |
Middle Eastern | 0.00158 | 0.00158 |
South Asian | 0.00964 | 0.00945 |
Other | 0.0141 | 0.0139 |
dbNSFP
Source:
- Function
- FUNCTION: Cleaves collagens of types I, II, and III at one site in the helical domain. Also cleaves collagens of types VII and X (PubMed:2557822, PubMed:2153297, PubMed:1645757). In case of HIV infection, interacts and cleaves the secreted viral Tat protein, leading to a decrease in neuronal Tat's mediated neurotoxicity (PubMed:16807369). {ECO:0000269|PubMed:1645757, ECO:0000269|PubMed:16807369, ECO:0000269|PubMed:2153297, ECO:0000269|PubMed:2557822}.;
- Pathway
- Relaxin signaling pathway - Homo sapiens (human);Bladder cancer - Homo sapiens (human);IL-17 signaling pathway - Homo sapiens (human);PPAR signaling pathway - Homo sapiens (human);Pathways in cancer - Homo sapiens (human);Rheumatoid arthritis - Homo sapiens (human);Matrix Metalloproteinases;Oncostatin M Signaling Pathway;Quercetin and Nf-kB- AP-1 Induced Cell Apoptosis;Bladder Cancer;Photodynamic therapy-induced NF-kB survival signaling;Hepatitis C and Hepatocellular Carcinoma;TGF-beta Signaling Pathway;PPAR signaling pathway;Protein alkylation leading to liver fibrosis;Interleukin-4 and 13 signaling;Signaling by GPCR;Assembly of collagen fibrils and other multimeric structures;Signal Transduction;Collagen degradation;Metabolism of proteins;Collagen formation;Extracellular matrix organization;Activation of Matrix Metalloproteinases;Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Glucocorticoid receptor regulatory network;Cell surface interactions at the vascular wall;Hemostasis;Degradation of the extracellular matrix;EGFR Transactivation by Gastrin;Posttranslational regulation of adherens junction stability and dissassembly;Basigin interactions;Gastrin-CREB signalling pathway via PKC and MAPK;G alpha (q) signalling events;GPCR downstream signalling;AP-1 transcription factor network;Syndecan-1-mediated signaling events;p75(NTR)-mediated signaling;Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling;Validated transcriptional targets of AP1 family members Fra1 and Fra2;Endothelins
(Consensus)
Recessive Scores
- pRec
- 0.810
Intolerance Scores
- loftool
- 0.907
- rvis_EVS
- 0.73
- rvis_percentile_EVS
- 86.27
Haploinsufficiency Scores
- pHI
- 0.487
- hipred
- N
- hipred_score
- 0.209
- ghis
- 0.399
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.851
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Mmp1b
- Phenotype
Gene ontology
- Biological process
- proteolysis;viral process;cytokine-mediated signaling pathway;extracellular matrix disassembly;extracellular matrix organization;collagen catabolic process;positive regulation of protein oligomerization;cellular protein metabolic process;leukocyte migration
- Cellular component
- extracellular region;extracellular space;extracellular matrix
- Molecular function
- endopeptidase activity;metalloendopeptidase activity;serine-type endopeptidase activity;zinc ion binding